• Home
• About Us
• Contact Us

• Targeted Delivery System (TDS)
• Product Development
  • Pipeline Chart
  • Rexin-G™
  •    Clinical Trials
  •    Rexin-G™ Fact Sheet
  •    About Metastatic Cancer
  • Reximmune-C™
  •    Clinical Trials
  •    Reximmune™ Fact Sheet
  • Publications
• Clinical Trials
• Licensing Opportunities
  • Oncology
  • Wound Healing
  • Stem Cells
  • Contact
• Media & Investor Relations
  • Press Releases
  •    Archives
  • Events
  • Publications

Epeius Biotechnologies is bringing genetic
medicine to the patient with Rexin-G™, the
world's first tumor-targeted gene delivery product.

© 2008 Epeius Biotechnologies Corporation. All rights reserved.